Search results
ICD 10 code for Anemia due to antineoplastic chemotherapy. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code D64.81.
Treatment of anaemia with an ESA should be considered in MDS patients with symptomatic anaemia, Hb < 10 g/dL, low to intermediate-1 risk (IPSS) or very low to intermediate risk (IPSS-R), less than two RBC transfusions per month and/or serum EPO < 500 IU/L [I, A]. At what doses should ESAs be given?
5 dni temu · Anemia due to Chemotherapy. Is it appropriate for the coding professional to assume a causal relationship between anemia and chemotherapy, blood loss or other deficiencies based on the subterm "due to" without provider documentation of the linkage?
D64.81 is a valid billable ICD-10 diagnosis code for Anemia due to antineoplastic chemotherapy. It is found in the 2025 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025 .
D64.81 is a billable/specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Anemia due to antineoplastic chemotherapy. Inclusion term Antineoplastic chemotherapy induced anemia
D64.81 is a billable diagnosis code used to specify a medical diagnosis of anemia due to antineoplastic chemotherapy. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
ICD-10 code D64.81 for Anemia due to antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism . Fill out the form below to download your FREE ICD-10-CM whitepaper.
